HCT 116 ADAM17 Cell Line showed that overexpression of ADAM-17 significantly decreases the effect of chemotherapy on tumor growth and apoptosis.
| Inventor | Institute |
|---|---|
| Sandra Van Schaeybroeck | Queen's University Belfast |
| SKU: | 153209 |
|---|---|
| Product description: | Chemotherapy (5-fluorouracil) treatment has been shown to result in acute increases in transforming growth factor-a, amphiregulin, and heregulin ligand shedding in vitro and in vivo correlating with significantly increased ADAM-17 activity. Small interfering RNAmediated silencing and pharmacologic inhibition confirmed that ADAM-17 was the principal ADAM involved in this prosurvival response. HCT 116 ADAM17 Cell Line showed that overexpression of ADAM-17 significantly decreases the effect of chemotherapy on tumor growth and apoptosis. |
| Conditional: | No |
| Production details: | HCT116 cells were cotransfected with 10 ÄÂÄ?g of a plasmid containing hemagglutinin (HA)-tagged full-length mouse ADAM-17 (HA-ADAM-17) and a construct expressing a puromycin resistance gene. Stably transfected cells were selected and maintained in medium supplemented with 1 ÄÂÄ?g/mL puromycin. |
| Additional notes: | Offered under licence from the Spanish National Research Council (CSIC) |
| Cellosaurus ID: | CVCL_HG03 |
| Parental cell line: | HCT 116 |
| Disease: | Cancer |
| Cat. #: | 153209 |
|---|---|
| Provenance and Ownership: | The HCT 116 ADAM17 Cell Line is owned by Cancer Research UK. CancerTools supplies the HCT 116 ADAM17 Cell Line under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing HCT 116 ADAM17 Cell Line directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Continuous |
| Unit size: | 1×10^6 cells / vial |
| Cancer types: | Colorectal cancer |
| Research Fields: | Cancer; Drug development |
| Organism: | Human |
| Tissue: | Colon |
| Model: | Knock-In |
| Growth properties: | Invasion, migration |
| Cancer Types In Detail: | Colorectal |
| Format: | Frozen |
|---|---|
| Shipping conditions: | Dry ice |
| Growth medium: | McCoy’s 5a Medium (GIBCO # 16600) + 10% FBS + 100 units/ml penicillin+ 100 ?g/ml streptomycin |
| Recommended controls: | HCT 116 parental line |
| References: |
Kyula et al. 2010. Clin Cancer Res. 16(13):3378-89. PMID: 20570921. Chemotherapy-induced activation of ADAM-17: a novel mechanism of drug resistance in colorectal cancer. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.